Global (United States, European Union and China) Artificial Heart Market Research Report 2019-2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Artificial Heart Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Ventricular Assist Device (VAD)
- 1.3.3 Total Artificial Heart
- 1.4 Market Segment by Application
- 1.4.1 Global Artificial Heart Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Artificial Heart Production Value 2014-2025
- 2.1.2 Global Artificial Heart Production 2014-2025
- 2.1.3 Global Artificial Heart Capacity 2014-2025
- 2.1.4 Global Artificial Heart Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Artificial Heart Market Size CAGR of Key Regions
- 2.2.2 Global Artificial Heart Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Artificial Heart Capacity by Manufacturers
- 3.1.2 Global Artificial Heart Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Artificial Heart Revenue by Manufacturers (2014-2019)
- 3.2.2 Artificial Heart Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Artificial Heart Market Concentration Ratio (CR5 and HHI)
- 3.3 Artificial Heart Price by Manufacturers
- 3.4 Key Manufacturers Artificial Heart Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Artificial Heart Market
- 3.6 Key Manufacturers Artificial Heart Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Ventricular Assist Device (VAD) Production and Production Value (2014-2019)
- 4.1.2 Total Artificial Heart Production and Production Value (2014-2019)
- 4.2 Global Artificial Heart Production Market Share by Type
- 4.3 Global Artificial Heart Production Value Market Share by Type
- 4.4 Artificial Heart Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Artificial Heart Consumption by Application
6 Production by Regions
- 6.1 Global Artificial Heart Production (History Data) by Regions 2014-2019
- 6.2 Global Artificial Heart Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Artificial Heart Production Growth Rate 2014-2019
- 6.3.2 United States Artificial Heart Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Artificial Heart Import & Export
- 6.4 European Union
- 6.4.1 European Union Artificial Heart Production Growth Rate 2014-2019
- 6.4.2 European Union Artificial Heart Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Artificial Heart Import & Export
- 6.5 China
- 6.5.1 China Artificial Heart Production Growth Rate 2014-2019
- 6.5.2 China Artificial Heart Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Artificial Heart Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Artificial Heart Consumption by Regions
- 7.1 Global Artificial Heart Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Artificial Heart Consumption by Type
- 7.2.2 United States Artificial Heart Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Artificial Heart Consumption by Type
- 7.3.2 European Union Artificial Heart Consumption by Application
- 7.4 China
- 7.4.1 China Artificial Heart Consumption by Type
- 7.4.2 China Artificial Heart Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Artificial Heart Consumption by Type
- 7.5.2 Rest of World Artificial Heart Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 SynCardia Systems
- 8.1.1 SynCardia Systems Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Artificial Heart
- 8.1.4 Artificial Heart Product Introduction
- 8.1.5 SynCardia Systems Recent Development
- 8.2 BiVACOR
- 8.2.1 BiVACOR Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Artificial Heart
- 8.2.4 Artificial Heart Product Introduction
- 8.2.5 BiVACOR Recent Development
- 8.3 CARMAT
- 8.3.1 CARMAT Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Artificial Heart
- 8.3.4 Artificial Heart Product Introduction
- 8.3.5 CARMAT Recent Development
- 8.4 Abbott
- 8.4.1 Abbott Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Artificial Heart
- 8.4.4 Artificial Heart Product Introduction
- 8.4.5 Abbott Recent Development
- 8.5 Cleveland Heart
- 8.5.1 Cleveland Heart Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Artificial Heart
- 8.5.4 Artificial Heart Product Introduction
- 8.5.5 Cleveland Heart Recent Development
- 8.6 AbioMed
- 8.6.1 AbioMed Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Artificial Heart
- 8.6.4 Artificial Heart Product Introduction
- 8.6.5 AbioMed Recent Development
- 8.7 Jarvik Heart
- 8.7.1 Jarvik Heart Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Artificial Heart
- 8.7.4 Artificial Heart Product Introduction
- 8.7.5 Jarvik Heart Recent Development
- 8.8 MyLVAD
- 8.8.1 MyLVAD Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Artificial Heart
- 8.8.4 Artificial Heart Product Introduction
- 8.8.5 MyLVAD Recent Development
- 8.9 Cirtec Medical Systems
- 8.9.1 Cirtec Medical Systems Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Artificial Heart
- 8.9.4 Artificial Heart Product Introduction
- 8.9.5 Cirtec Medical Systems Recent Development
- 8.10 Thoratec Corporation
- 8.10.1 Thoratec Corporation Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Artificial Heart
- 8.10.4 Artificial Heart Product Introduction
- 8.10.5 Thoratec Corporation Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Artificial Heart Capacity, Production Forecast 2019-2025
- 9.1.2 Global Artificial Heart Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Artificial Heart Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Artificial Heart Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Artificial Heart Production Forecast by Type
- 9.7.2 Global Artificial Heart Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Artificial Heart Sales Channels
- 10.2.2 Artificial Heart Distributors
- 10.3 Artificial Heart Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Artificial hearts are being used to help patients with total heart failure live normal lives past their life expectancy time line, or to help patients survive until their transplant date either by replacing the heart completely or by replacing the ventricles. The device is surgically implanted in the chest in order to help in the functioning of a deteriorating heart. An artificial heart may also be used temporarily and is removed once the heart starts functioning normally. In cases where the damage is severe, the biological heart is completely replaced with the artificial heart. An artificial heart is powered by either compressed air or electricity.
The rise in the number of cardiac disorders along with an increase in the geriatric population is anticipated to drive the artificial heart market in the coming years. Improper lifestyle, leading to deteriorating cardiac condition is expected to offer growth opportunities during the forecast period for the manufacturers of artificial heart.
North America is expected to contribute to the largest share in the artificial heart market in the coming years, due to technological advancements as well as improved treatment of cardiac conditions in United States and Canada. Asia Pacific is expected to record substantial demand for artificial heart market during the forecast period, due to the rise in geriatric population in various Asian countries.
In 2019, the market size of Artificial Heart is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Artificial Heart.
This report studies the global market size of Artificial Heart, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Artificial Heart production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
SynCardia Systems
BiVACOR
CARMAT
Abbott
Cleveland Heart
AbioMed
Jarvik Heart
MyLVAD
Cirtec Medical Systems
Thoratec Corporation
Market Segment by Product Type
Ventricular Assist Device (VAD)
Total Artificial Heart
Market Segment by Application
Hospitals
Clinics
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Artificial Heart status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Artificial Heart manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Artificial Heart are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025